Anixa Biosciences CEO Discusses Cancer Immunotherapy Innovations in Smart Money Circle Interview #United_States #Anixa_Biosciences #San_Jose #Cancer_Immunotherapy #Dr._Amit_Kumar
0
0
0
0
Hashtag
#Cancer_Immunotherapy
Advertisement · 728 × 90
TuHURA Biosciences Releases Fourth Quarter and Full Year Financial Results for 2025 #United_States #Tampa #Cancer_Immunotherapy #TuHURA_Biosciences #HURA
0
0
0
0
GNTbm-38 Receives FDA IND Approval for Phase I Clinical Trials, Promising New Hope in Cancer Immunotherapy #Taipei #USA #FDA_Approval #Cancer_Immunotherapy #GNTbm-38
1
0
0
0
TuHURA Biosciences Achieves Compliance with Nasdaq Listing Standards Following Remarkable Stock Recovery #United_States #NASDAQ #Tampa #Cancer_Immunotherapy #TuHURA_Biosciences
1
0
0
0
Parker Institute for Cancer Immunotherapy Appoints Bob Purcell as New Chief Communications Officer #United_States #San_Francisco #Cancer_Immunotherapy #Parker_Institute #Bob_Purcell
0
0
0
0
Compugen Set to Showcase Innovations in Cancer Immunotherapy at Upcoming Investor Conferences #Israel #Cancer_Immunotherapy #Holon #AI_Powered #Compugen_Ltd
0
0
0
0
Cancer Stress Protein: A Pioneering Discovery in Immune Evasion Mechanisms #United_States #New_York #Cancer_Immunotherapy #NYU_Langone #lipocalin_2
0
0
0
0
Oricell Therapeutics Secures $70M to Propel CAR-T Therapy Development in Oncology #China #Shanghai #Cancer_Immunotherapy #CAR-T_therapy #Oricell_Therapeutics
1
0
0
0
American Skin Association Welcomes Steven A. Rosenberg to Its Board to Enhance Skin Health Advocacy #USA #New_York #Cancer_Immunotherapy #American_Skin_Association #Steven_A._Rosenberg
0
0
0
0
TuHURA Biosciences Initiates $15.6 Million Fundraising Through Registered Direct Offering #USA #Tampa #Cancer_Immunotherapy #TuHURA #IFx-2.0
0
0
0
0
TuHURA Biosciences Unveils Delta Opioid Receptor Role at ASH Annual Meeting #USA #Orlando #Cancer_Immunotherapy #TuHURA_Biosciences #Delta_Opioid_Receptor
0
0
0
0
Mark Veich Appointed as Chief Organizational Advancement Officer at PICI #USA #San_Francisco #Cancer_Immunotherapy #Parker_Institute #Mark_Veich
0
0
0
0
Accession Therapeutics Marks Milestone with TROCPT-01 Clinical Trial Initiation in Cancer Treatment #United_Kingdom #Oxford #Cancer_Immunotherapy #Accession_Therapeutics #TROCEPT-01
0
0
0
0
Compugen's Third Quarter 2025 Financial Performance and Clinical Updates Highlight Its Strategic Direction #Israel #Cancer_Immunotherapy #Compugen #Holon #COM701
0
0
0
0
Lunai Bioworks Achieves Groundbreaking Success in Pancreatic Cancer Treatment Using AI-Enhanced Immunotherapy #USA #Los_Angeles #Cancer_Immunotherapy #pancreatic_cancer #Lunai_Bioworks
0
0
0
0
Lunai Bioworks Revolutionizes Cancer Treatment with Breakthrough Immunotherapy for Pancreatic Cancer #USA #Los_Angeles #Cancer_Immunotherapy #Lunai_Bioworks #Pancreatic_Tumors
0
0
0
0
Parker Institute Showcases Pioneering Advances in Immunotherapy at SITC 2025 Annual Meeting #USA #Cancer_Immunotherapy #National_Harbor #Parker_Institute #SITC_2025
0
0
0
0
SITC Unveils Groundbreaking Abstracts at 40th Anniversary Annual Meeting #United_States #Cancer_Immunotherapy #National_Harbor #SITC #late-breaking
0
0
0
0
ACM Biolabs Unveils Promising Early Clinical Results in Cancer Immunotherapy #Singapore #Cancer_Immunotherapy #ACM_Biolabs #ACM-CpG
0
0
0
0
Breakthrough in Cancer Immunotherapy: New Gene Signature Revealed for T Cell Proliferation Prediction #Japan #Tokyo #Cancer_Immunotherapy #T_Cell_Proliferation #Gene_Signature
1
0
0
0
iOncologi's Patented RNA Innovations Promise Enhanced Cancer Immunotherapy Outcomes #United_States #Gainesville #Cancer_Immunotherapy #RNA_Therapies #iOncologi
0
0
0
0
GNTbm Unveils Promising Preclinical Findings for GNTbm-TKI at ESMO 2025 #Taiwan #Taipei #Cancer_Immunotherapy #GNTbm-TKI #Advanced_Oncology
0
0
0
0
Revolutionary Advancements in Cancer Treatment Projected to Reach $643B by 2034 #None #Cancer_Immunotherapy #GT_Biopharma #Lexeo_Therapeutics
0
0
0
0
Kazia Therapeutics Unveils Collaboration on Innovative PD-L1 Protein Degrader Program #Australia #Sydney #Cancer_Immunotherapy #Kazia_Therapeutics #PD-L1_Degrader
0
0
0
0
The Surge in Cancer Immunotherapy: $258 Billion Market Set for Growth Following FDA Approvals #USA #Vancouver #Cancer_Immunotherapy #Oncolytics_Biotech #FDA_Approvals
0
0
0
0
PhotonPharma's New Patent Marks a Breakthrough in Cancer Immunotherapy Development #United_States #Fort_Collins #Cancer_Immunotherapy #PhotonPharma #Innocell
0
0
0
0
BioVaxys Technology Corp. Launches New Convertible Debenture Offering #Canada #Vancouver #Cancer_Immunotherapy #BioVaxys #Convertible_Debentures
0
0
0
0
Anixa Biosciences Set to Shine at H.C. Wainwright Global Investment Conference #United_States #New_York #Anixa_Biosciences #Cancer_Immunotherapy #H.C._Wainwright
0
0
0
0
ARC Therapies Innovates Gut Microbiome Research with YB328 for Cancer Treatment #Japan #Cancer_Immunotherapy #Shinjuku #ARC_Therapies #YB328
0
0
0
0
Society for Immunotherapy of Cancer Celebrates 40 Years with Special Awards #Cancer_Immunotherapy #SITC #40th_Anniversary
1
1
0
0